Background: If used in the right clinical context, PCRs carry great potential in rapidly diagnosing various infectious diseases. Objectives: We aimed to evaluate the clinical performance of four novel multiplex real-time PCR (qPCR) assays in the direct detection of pathogens in whole blood, cerebrospinal fluid, respiratory specimens, and stool samples. Methods: Spiked negative clinical specimens were used for the evaluation. Clinical samples for the comparative assessment of culture and molecular analyses were simultaneously examined. RINATM robotic nucleic acid isolation system and Bio-Speedy® multiplex qPCR panels (Bioeksen R&D Technologies, Turkey), and the LightCycler® 96 Instrument (Roche, USA) were used for the molecular testing. Results: No qPCR assays produced positive results for the samples spiked with the potential cross-reacting pathogens. The limit of detection (LOD) of the assays changed with the use of 10 and 100 pathogens/mL sample based on the target and sample type. The relative sensitivity and specificity of the assays were, respectively, 82% and 94% for blood, 97.1% and 99.3% for blood culture, 94% and 98% for stool, 96% and 97% for CSF, and 97% and 96% for respiratory specimens. Conclusions: The panels evaluated allow the direct molecular analysis of 10 samples from four clinical syndromes on the same run in 3 h with high clinical performance. The number and variety of samples in a single run enable healthcare providers to rapidly and efficiently diagnose and treat various infections.
30 August 2020 in Journal of Academic Research in Medicine
Background Bloodstream infections (BSIs) remain a major cause of morbidity and mortality, particularly in hospitalized patients with sepsis. Rapid identification of pathogens and their resistance profiles is critical for timely initiation of effective antimicrobial therapy, as delays can substantially increase mortality. This prospective study aimed to compare conventional culture-based methods with Multiplex Real-Time PCR (RT-PCR) for the early detection of pathogens and resistance genes in blood culture samples exhibiting positive signals. Methods A total of 100 hospitalized patients with suspected sepsis were included in the study. Blood culture samples were analyzed using both conventional culture methods and multiplex real-time PCR. Conventional methods identified 108 microorganisms, whereas RT-PCR detected pathogens in 90 samples, After the blood culture bottle signaled positive, the samples were inoculated onto culture media. Subsequently, multiplex PCR was performed, and results were obtained within approximately 2–4 h. The subcultured samples were evaluated the following day, identified using MALDI-TOF MS, and antimicrobial susceptibility testing was performed. Both identification and susceptibility results were reported on the second day.along with an additional 14 microorganisms that were not recovered by culture. Results Resistance gene profiles identified by RT-PCR demonstrated high concordance with phenotypic resistance results, including mecA/C, VIM, NDM, KPC, and vanA genes. Nevertheless, discrepancies such as very major errors (5.1%) were observed, indicating areas requiring further investigation. Conclusion Multiplex RT-PCR serves as a valuable adjunct to conventional culture methods, enabling rapid pathogen identification and resistance profiling. Its integration into routine diagnostic workflows may enhance clinical outcomes by facilitating timely, targeted therapy for septic patients.
Background: Obesity is among the important healthcare issues in which there is an abnormal increase in body fat because energy intake is higher than energy expenditure. The Tumor Necrosis Factor (TNF)-alpha overexpression in adipose tissue plays important roles in mediating obesity and insulin resistance. “TNF-related apoptosis-inducing Ligand (TRAIL(TNSF10))”, which is a member of the TNF family, is expressed as a Type-II Transmembrane Protein with an effect on the development of obesity and diabetes. Methods: The rs781673405, rs1244378045, rs767450259, rs750556128, rs369143448, rs143353036, and rs759369504 polymorphisms of TRAIL, which were determined to play protective roles against diabetes, were evaluated with the RT-qPZR Method in the present study. Results: It was found that the genotype distribution of TRAIL rs767450259 Polymorphism was significant and the T-Allele had protective effects against diabetic obesity. It was also found that the G-Allele of the rs369143448 Polymorphism had protective roles against diabetic obesity. It was shown that carrying the A-Allele in the rs750556128 Polymorphism might increase the risk of obesity in diabetic patients by 1.3-fold. Conclusions: The present study makes a significant contribution to the literature data because it is the first to investigate these polymorphisms.